L189 inhibits base excision repair (BER) and non-homologous end joining (NHEJ), which specifically sensitizes cancer cells to DNA damage and increases the cytotoxicity of DNA-damaging agents. L189 will not only provide insights into the cellular function of these enzymes but also serve as lead compounds for the development of anticancer agents.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | L189 |
| Iupac 化学名称 | (E)-6-amino-5-(benzylideneamino)-2-thioxo-2,3-dihydropyrimidin-4(1H)-one |
| 同义词 | L189; L 189; L-189 |
| 英文同义词 | L189; L 189; L-189 |
| 分子式 | C11H10N4OS |
| 分子量 | 246.29 |
| Smile | NC1=C(C(NC(N1)=S)=O)/N=C/C1=CC=CC=C1 |
| InChiKey | SAKOXVNKDMWWLF-AWNIVKPZSA-N |
| InChi | InChI=1S/C11H10N4OS/c12-9-8(10(16)15-11(17)14-9)13-6-7-4-2-1-3-5-7/h1-6H,(H4,12,14,15,16,17)/b13-6+ |
| Cas号 | 64232-83-3 |
| 相关CAS号 | |
| 外观性状 | Solid powder |
| 纯度 | 98% |
| 存储 | -20 ºC for 3 years |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |